MDM2 and neoplasm: MI-63 and MI-219 are small molecules also designed to block the interaction between p53/MDM2 and early preclinical evaluations demonstrated p53-mediated cell cycle arrest or apoptosis in tumor xenograft models upon treatment with Mi-219 (Shangary et al., 2008).